Latest News and Press Releases

OCEANSIDE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions International, Inc., (USOTC: TSOI) announced today further refinement of their patented formulation of...

OCEANSIDE, Calif., Jan. 22, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions International, Inc., (USOTC:TSOI) announced today an additional expansion to their CTE portfolio of...

OCEANSIDE, Calif., Jan. 14, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today early results of a clinical trial suggesting...

OCEANSIDE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today the addition and expansion to their CTE...

OCEANSIDE, Calif., Dec. 31, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) addresses shareholders in letter form. We have had a...

OCEANSIDE, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutic Solutions International, Inc., (OTC Markets: TSOI) announced today the signing of an agreement between TSOI and...

OCEANSIDE, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today data demonstrating that modification of...

OCEANSIDE, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today a newly optimized formulation of NeuroStilbene...

OCEANSIDE, Calif., Sept. 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Therapeutics Solutions International, Inc. (OTC Markets: TSOI) announced today filing of a patent covering novel clinical...

Company Files Patent and Generates Proof of Concept Data using NeuroStilbene for Prevention of Football Associated Brain Damage OCEANSIDE, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) --  via OTC PR...